← Insider buys
RPRX

Royalty Pharma plc · Healthcare

EVP and CFO Terrance P. Coyne sold $1.6M of Royalty Pharma plc

Sold$1,576,606
$45.32Price
34,791Shares
−13%Stake

What RPRX did after the filing

Filed Feb 25Copier in Feb 26
The stock from Thu, Feb 26 open, $45.00
+6.0%
S&P 500, same days
−2.0%

Measured over 30 trading days, to the Apr 10 close.

Traded Mon, Feb 23. Filed Wed, Feb 25, 4:08 PM ET, after the close. Returns use the Feb 26 open and the Apr 10 close. Not investment advice.